Cargando…
Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V. and International Society of Chemotherapy.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243754/ https://www.ncbi.nlm.nih.gov/pubmed/32450201 http://dx.doi.org/10.1016/j.ijantimicag.2020.106023 |
| _version_ | 1783537461668872192 |
|---|---|
| author | Gaspari, Valeria Zengarini, Corrado Greco, Sonia Vangeli, Valeria Mastroianni, Antonio |
| author_facet | Gaspari, Valeria Zengarini, Corrado Greco, Sonia Vangeli, Valeria Mastroianni, Antonio |
| author_sort | Gaspari, Valeria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7243754 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier B.V. and International Society of Chemotherapy. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72437542020-05-22 Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports Gaspari, Valeria Zengarini, Corrado Greco, Sonia Vangeli, Valeria Mastroianni, Antonio Int J Antimicrob Agents Letter to the Editor Elsevier B.V. and International Society of Chemotherapy. 2020-08 2020-05-22 /pmc/articles/PMC7243754/ /pubmed/32450201 http://dx.doi.org/10.1016/j.ijantimicag.2020.106023 Text en © 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Gaspari, Valeria Zengarini, Corrado Greco, Sonia Vangeli, Valeria Mastroianni, Antonio Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports |
| title | Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports |
| title_full | Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports |
| title_fullStr | Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports |
| title_full_unstemmed | Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports |
| title_short | Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports |
| title_sort | side effects of ruxolitinib in patients with sars-cov-2 infection: two case reports |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243754/ https://www.ncbi.nlm.nih.gov/pubmed/32450201 http://dx.doi.org/10.1016/j.ijantimicag.2020.106023 |
| work_keys_str_mv | AT gasparivaleria sideeffectsofruxolitinibinpatientswithsarscov2infectiontwocasereports AT zengarinicorrado sideeffectsofruxolitinibinpatientswithsarscov2infectiontwocasereports AT grecosonia sideeffectsofruxolitinibinpatientswithsarscov2infectiontwocasereports AT vangelivaleria sideeffectsofruxolitinibinpatientswithsarscov2infectiontwocasereports AT mastroianniantonio sideeffectsofruxolitinibinpatientswithsarscov2infectiontwocasereports |